| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-07 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
8e-05 |
| mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |